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Abstract: Dental luting cements are commonly used in dentistry for cementation of prosthetic
restoration. Many previous studies focused on the measurement of the cell viability as the
method of cytotoxicity evaluation during biocompatibility study for the material. In this study, the
biocompatibility of various dental luting cements were evaluated using the new method of cytokine
release measurement in order to better simulate inflammatory reactions in animal or clinical model
using two different oral cells; immortalized human gingival fibroblast and immortalized human
oral keratinocytes. Cells were exposed to extractions of various commercially available dental
luting cements for different durations. Cytokines of IL-1α and IL-8 were measured from the
supernatants of the cells and the results were then compared to the conventional MTT viability
test. The result from the conventional cell viability study showed a relatively simple and straight
forward indication that only one of the dental luting cements tested in this study was cytotoxic with
increasing duration of exposure for both cells. Meanwhile, the result from the cytokine measurement
study was much more complex at the time point they were measured, type of cells used for the
study and the type of cytokines measured, all of which influenced the interpretation of the results.
Hence, the better understanding of the cytokine release would be required for the application in
biocompatibility evaluation.
Keywords: biocompatibility; cytokine; cytotoxicity; dental luting cement; fibroblast; inflammation;
keratinocyte
1. Introduction
Dental luting cements are commonly used in dentistry for cementation of prosthetic restoration,
for which the selection of the right cement is important to achieve long-term success of fixed
restoration [1]. Various luting cements are currently available in the market, including glass ionomer
cement (GIC), resin-modified glass ionomer cement (RMGIC), and resin-composite cement (RC), each
with distinct characteristics [2].
GIC was introduced in early 1970s, has been used as a restorative material because of its
fluoride-releasing properties, but has also been used as a luting cement because of its chemical
property that allow its adhesion to the mineralized tissue [2,3]. RMGIC is a hybrid formulation
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between resin and glass ionomer components that retains the advantages of GIC, but also provides
better setting characteristics and improved mechanical properties compared to the conventional
GIC [4]. Finally, RC, which is polymerized by chemical initiation, photo initiation or a combination
of both, has been used especially to meet esthetic demands [5].
Along with the above chemical and mechanical properties, biocompatibility of dental cement
is also an important requirement that is essential for the acceptance of the materials [6]. It has
been reported that some dental luting cements are cytotoxic to the dental pulp cells and cause
hypersensitivity in animal studies [7]. There have also been numerous biocompatibility studies of
dental luting cement using cell culture techniques with various cells, such as gingival fibroblasts [8],
dental pulp cells [9,10] and mouse fibroblasts [11]. However, all of the previous studies focused on
the viability of the cells as the method of cytotoxicity evaluation for dental cements, method which
have often been criticized due to the poor correlation with either animal studies or clinical results, as
it does not reflect inflammatory mechanisms of the body system [12].
Hence, the purpose of this study was to investigate the biocompatibility of various dental
luting cements using both immortalized human oral fibroblasts and immortalized human oral
keratinocytes by methods of cytokine release measurement. Two cytokines that have significant role
in inflammatory mechanisms of the human body were considered in this study, IL-1α that plays a
major role in regulating the release of other cytokines [13], and IL-8 that promotes wound healing
through control of other cytokines and inducing growth factors expressions [14]. The results were
then compared to the conventional viability test to suggest possible means of correlating the results.
2. Experimental Section
2.1. Cells and Cell Culture
Two different human oral cells were used in this study; immortalized human gingival fibroblast
(hTERT-hNOF) and immortalized human oral keratinocytes (IHOK). The hTERT-hNOF cells were
derived from gingival fibroblasts that were primarily cultured from healthy human adults and
transfected with puromycin-resistant retroviral vector plpc-hTERT (Clonetech Laboratories, Palo
Alto, CA, USA). Previous studies have confirmed sub-culturing beyond the 90th passage without
signs of replicative senescence and feasibility of biocompatibility evaluation has been shown [15,16].
IHOK were obtained from immortalization of human gingival epithelial cells by transfecting
with the pLXN vector containing E6/E7 open reading frame of HPV type 16 as the method described
previously [17].
Both cells were cultured in culture medium of Dulbecco’s Modified Eagle’s Medium mixed
with Ham’s Nutrient Mixture F-12 in 3 to 1 ratio (DMEM/F12 3:1, Gibco, Grand Island, NY, USA).
Additionally, 10% fetal bovine serum (Gibco, Grand Island, NY, USA) and 1% penicillin/streptomycin
(Invitrogen, Grand Island, NY, USA) was added to the culture media and cells were cultured at
37 ˝C in a fully humidified atmosphere of 5% CO2. Despite the high calcium level of the media,
and therefore not being optimal for the growth of IHOK, the selection of media was based on
the consistency in extraction of the test materials as a different media would result in a different
polarity, which would consequently cause different chemicals being extracted for the biocompatibility
evaluations. In addition, it was confirmed that the DMEM/F12 3:1 media had no inhibition on growth
of IHOK during the preliminary experiments (results not included) as well as in previously published
studies [18].
2.2. Dental Luting Cements and Extraction
One of each commercially available GIC, RMGIC, and RC were evaluated in this study
that was given with the code for the purpose of this manuscript (Table 1). All samples were
checked for expiration dates and stored under manufacturers’ recommended conditions throughout
the experiment.
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Samples for extraction were made by mixing the material thoroughly according to the
manufacturer’s instruction and placing each sample into a 16 mm diameter, 2 mm thick Teflon mold.
The materials were then allowed to set, where, in case of RU, light curing was took place using
a light-emission diode (LED) curing unit (Elipar S10, 3M ESPE, St. Paul, MN, USA) for 20 s on 5
different sides of the sample.
Extracts from each type of cement were prepared according to the international standard and
adaptated from a previous study [16,19,20]. Briefly, all samples were sterilized with ethylene oxide
gas and extracted in serum free culture media where the volume was determined from the surface
area of the samples (1.25 mL/cm2). Each type of cement was then extracted for 24 h at 37 ˝C. The
serum free cell culture media without the sample was also incubated in the same condition as the test
material extracts and used as the negative control of this experiment.
Table 1. Summary of dental luting cements used in this study.
Name Code Type Batch No. Manufacturer
Fuji I FI Glass ionomer cement 1207301 GC Corp., Tokyo, Japan
Fuji Plus FP Resin-modified glassionomer cement 1209181 GC Corp., Tokyo, Japan
Rely X U200 RU Resin cement 498329 3M ESPE, St. Paul, MN, USA
2.3. Cell Viability Test
A cell viability test was carried out according to international standards [21] using the
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay that generate formazan
directly proportional to the number of viable cells by NADH-dependent cellular oxidoreductase
enzyme of the mitochondria [22]. Briefly, 1 ˆ 104 of each cell was cultured in a standard 96-well
plate (SPL, Gyeongi-do, Korea), in 100 µL of culture medium for 24 h. Following removal of the
culture medium, and washing with Dulbecco’s phosphate buffer saline (Gibco, Grand Island, NY,
USA), 100 µL of extractions from each type of cement (as described earlier) and negative control were
placed on each cell. Cells were then incubated for 1.5 h, 3 h, 6 h, 12 h, 24 h, 36 h, 48 h, 60 h and 72 h at
37 ˝C and the supernatant from each cell was collected for cytokine release assay, which the method
will be described below. Following removal of culture media, 50 µL of MTT solution (Sigma-Aldrich,
St. Louis, MO, USA) was added to each well and incubated for further 2 h. MTT solution was then
removed and 100 µL of isopropanol (Sigma-Aldrich, St. Louis, MO, USA) was added into each well
that solubilize the formazan product. The optical density of each well was then measured using a
microplate spectrophotometer (Epoch, BioTek Instrument, Winooski, VT, USA) at 570 nm following
1 h of shaking and the cell viability was calculated as the percentage of the optical density measured
for the negative control.
2.4. Cytokine Release Test
Cell supernatant that was collected from above cell viability test was used for the cytokine release
test. First, 50 µL of the supernatant from each of cells exposed to dental luting cement extracts
or negative control were reacted with 50 µL of either mouse anti-human interleukin-1α (IL-1α) or
interleukin-8 (IL-8) (R&D System Inc., Minneapolis, MN, USA) in standard 96-well plate for 2 h at
room temperature. After the reaction, each well was washed three times with 0.05% Tween 20 in
PBS (Sigma-Aldrich, St. Louis, MO, USA) and reacted with 50 µL of biotinylated goat anti-human
IL-1α or IL-8 (R&D System Inc., Minneapolis, MN, USA). Each well was washed again with 0.05%
Tween 20 in PBS (Sigma-Aldrich, St. Louis, MO, USA) and 50 µL of streptavidin conjugated to
horseradish-peroxidase (R&D System Inc., Minneapolis, MN, USA) was added to each well. After
final washing with 0.05% Tween 20 in PBS (Sigma-Aldrich, St. Louis, MO, USA), color was developed
with tetramethylbenzidine (TMB, Sigma-Aldrich, St. Louis, MO, USA) and the reaction was stopped
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by 2 N H2SO4 (Sigma-Aldrich, St. Louis, MO, USA). The absorbance of each well was measured
at 450 nm using a microplate spectrophotometer (Epoch, BioTek Instrument, Winooski, VT, USA)
and levels of IL-1α and IL-8 were determined using calibrated curve drawn by dilutions of standard
recombinant human IL-1α or IL-8 (R&D System Inc., Minneapolis, MN, USA).
2.5. Statistical Analysis
Each dental luting cement was tested with 8 wells of cultured cells for each time period of
exposure and the entire experiment was repeated three times. The results of cell viability test and
cytokine release assay were subjected to statistical analysis with the one-way ANOVA (PASW 18.0,
IBM Co., Armonk, NY, USA), where Tukey method was adapted as a post hoc test, and the significance
was declared at p < 0.05. All values were stated as mean ˘ standard deviations.
3. Results
3.1. Cell Viability Test
The results of cell viability test measured by MTT assay for three different types of dental luting
cements are shown in Figures 1 and 2.
In terms of cell viability of IHOK, cells exposed to extraction of FP showed the lowest cell
viability (p < 0.05) for each time period of exposure (1.5 h to 72 h) and there was a decrease in cell
viability with the passage of time for FP (Figure 1). However, there was no significant difference
between cells exposed to FI, RU and negative control (p > 0.05), and high level of cell viability was
maintained for both FI and RU with the passage of time.
The results showed similar trend with cell viability of hTERT-hNOF following exposure to dental
luting cements, though high level of cell viability was observed following short duration of exposure
(1.5 h, 3 h, and 6 h) to extraction of FP (Figure 2).
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Figure 1. Cell viability of immortalized human oral keratinocytes (IHOK) following exposure to Fuji
I (FI), Fuji Plus (FP) and Rely X U200 (RU) for varying duration of time.
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For IHOK, general  increase of IL‐1α release as the  increasing duration of extraction exposure 
was noted for all of test and control group (Figure 3a). In addition, high level of IL‐1α was detected 
following  exposure  to  extraction  of  FP  for  24  h  or  longer  than  any  other  dental  luting  cements  
(p < 0.05) and  there was no significant difference  in  IL‐1α  level  following exposure  to FI, RU and 
negative control (p > 0.05) (Figure 3a). 
 
Figure 3. (a) Concentration of IL‐1α and (b) IL‐8 released from immortalized human oral keratinocytes 
(IHOK) following exposure to Fuji I (FI), Fuji Plus (FP) and Rely X U200 (RU) for varying duration of time.  
  
Figure 2. Cell viability of immortalized human oral fibroblasts (hTERT-hNOF) following exposure to
Fuji I (FI), Fuji Plus (FP) and Rely X U200 (RU) for varying duration of time.
3.2. Cytokine Release Test
The results f cytokine release test for IL-1α and IL-8 from both IHOK and hTERT-hNOF
following exposure to extraction of three different types of dental luting cements are shown in
Figures 3 and 4.
For IHOK, general increase of IL-1α release as the increasing duration of extraction exposure
was noted for all of test and control group (Figure 3a). In addition, high level of IL-1α was detected
following exposure to extraction of FP for 24 h or longer than any other dental luting cements
(p < 0.05) and there was no significant difference in IL-1α level following exposure to FI, RU and
negative control (p > 0.05) (Figure 3a).
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Figure 3. (a) Concentration of IL-1α and (b) IL-8 released from immortalized human oral keratinocytes
(IHOK) following exposure to Fuji I (FI), Fuji Plus (FP) and Rely X U200 (RU) for varying duration
of time.
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The results for IL-8 released from IHOK were similar to IL-1α except for the IHOK exposed to
extraction of FP. First, there was no significant difference among all test and control group until 12 h
of exposure (p > 0.05) (Figure 3b). At the point of 24 h exposure, IHOK exposed to extraction of FP
showed significantly higher level of IL-8 than FI, RU and negative control (p < 0.05). However, at 36
h of exposure, there was no significant difference between all of the test and control groups as before,
and finally the IL-8 released from IHOK following exposure to extraction of FP showed significantly
lower level of IL-8 compare to FI, RU and negative control from 48 h to 72 h of exposure (p < 0.05)
(Figure 3b).
In terms of hTERT-hNOF, it was very difficult to detect IL-1α from any of the hTERT-hNOF
exposed to dental luting cements and negative control (Figure 4a). There was, however, increasing
level of IL-8 released from hTERT-hNOF at increasing exposure times to dental luting cements and
negative control, and there was no significant difference between all of test and control groups
(p > 0.05) (Figure 4b).
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4. Discussion
Biocompatibility of dental luting cements is an important feature of the material, as with any
dental materials, in order to avoid potential adverse biological effects when applied to patients in
clinics [23]. In this study, three different types of dental luting cement, GIC, RMGIC and RC, were
examined for in vitro cytotoxicity as part of biocompatibility evaluation using two different cell lines,
hTERT-hNOF and IHOK.
First, a cell viability test using MTT assay was carried out, which showed that RMGIC tested
in this study (FP) was significantly more cytotoxic than the other types of dental luting cements and
than negative control for both cell types (Figures 1 and 2). This result was in agreement with previous
study that used human dental pulp stem cells that showed high level of cytotoxicity by FP due to
excessive fluoride ion release and the presence of monomer in extracts [10]. Indeed, such cell viability
test is useful in terms of evaluation of large number of materials and as indication of cellular metabolic
activity [24,25]. However, it has often been suggested that careful consideration shall be given to such
test, as it cannot reflect the tissue inflammatory responses that take place during both in vivo and
clinical studies [12]. Hence, additional test that considered the inflammatory response was carried
out in this study, the cytokine release test.
Initial interesting findings from cytokine release test was that there was no or very low level
of IL-1α released from hTERT-hNOF cells. This result was somewhat in agreement with a previous
study by Moharamzadeh et al. who showed that there was no IL-1β released from human gingival
fibroblasts [26]. However, unlike their findings, which showed that HaCaT keratinocyte did not
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release any IL-1β either, the results in this study showed that IHOK managed to produce IL-1α from
the extraction of dental luting cement, which may be due to the fact that different components of
IL-1 was investigated (α instead of β) or due to the difference in sites where primary culture for
immortalized cell line was obtained (skin tissue in HaCaT and oral tissue for IHOK).
In terms of the result of the other cytokine release test, significantly higher level of IL-1α was
released from IHOK cells exposed to extraction of FP (Figure 3a), which was in agreement with cell
viability test results. However, unlike the cell viability test, there was no significant difference in IL-8
released from any of the test and control materials for hTERT-hNOF cells (Figure 4b). Even more
interestingly, significantly low level of IL-8 release was identified following exposure of FP extraction
to IHOK for 48 h or longer (Figure 3b), which is a completely opposite trend to the cell viability
test results.
It is well known from previous in vivo animal studies and ex vivo organotypic tissue that oral
mucosa cells are capable of producing both IL-1α and IL-8, even without any stimulation [27].
This was evident in this study as both cytokines were released (except IL-1α from hTERT-hNOF
as mentioned above), even with exposure to negative control. In addition, oral mucosa keratinocytes
have been known as the major source of IL-1α [27] and among many other roles of IL-1α, its major role
is to regulate release of other cytokines such as IL-6 or IL-8 [13]. IL-8 then plays a role in promotion
of wound healing through controlling other cytokines and inducing growth factors expressions [14].
Although the role and interaction between each cytokines are still unclear, the results seen in this
study may have been due to the initial regulator of IL-1α that was released constantly by the presence
of cytotoxic material, whereas the active component of IL-8 level may vary according to the time
period depending on both IL-1α level and feedback from other cytokines. Still, it is expected that such
variation of both cytokine level according to the duration of dental luting cement exposure would
result in different response in animal studies compare to simple difference seen in cell viability results.
In order to confirm the findings of this study and provide explanations for the results, molecular
studies such as real-time quantitative reverse transcription polymerase chain reaction is currently
underway for the IL-1α, IL-8, and other cytokines such as TNF-α, as the further investigations are
outside the scope of this paper.
The interest toward the development of in vitro biocompatibility study that is an alternative to
animal experiment is currently increasing, which the key issue is to simulate and predict biological
reaction to materials when it is placed in the body through in vitro studies [28]. In this study,
measurement of two cytokines, IL-1α and IL-8, was carried out on both keratinocytes and fibroblasts
following exposure to different dental luting cements. The study has few limitations including use of
DMEM/F12 3:1 media, which is not optimal for IHOK. Still, the results here showed the importance
of considering three key factors during the measurement of cytokines as part of biocompatibility test:
(1) consideration of cell type; (2) consideration of time point for measurement; and (3) consideration
of cytokine type. These consideration and understandings would provide useful information in
terms of applying method of cytokine measurement as in vitro biocompatibility study for any
dental or biological materials. This would also provide foundation to the alternative test method
for animal studies, by considering more clinically relevant in vitro biocompatibility study for the
dental materials.
5. Conclusions
In this study, two cytokines, IL-1α and IL-8, were measured from two different cell lines, IHOK
and hTERT-hNOF, following extraction of various commercially available dental luting cements to
investigate possibilities of using them as method for biocompatibility evaluation. It was evident
that type of cells used, type of cytokines measured and time point of measurement all influenced the
interpretation of results. Understanding these three factors in link with conventional cell viability test
studies as well as the animal or clinical studies would be required for better application of cytokine
measurement for biocompatibility evaluation of biomaterial including dental luting cements.
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